PharmaVOICE - 
May 2002
Purchase Issue

In Every Issue
Talent Pool
Pharma POOL Robert GELBARD ICN Pharmaceuticals Appoints Former Ambassador to [...]
By
E-Media
NEW ELECTRONIC AND WEBBASED APPLICATIONS, SITES, AND TECHNOLOGIES BioSpace Inc., [...]
By
What’s New
WHAT’S NEW NEW HEALTHCARERELATED PRODUCTS, SERVICES, AND COMPANIES Noonan Russo [...]
By

http://www.pharmavoice.com/?p=241735

PharmaTrax
Extending its line of therapeutic class research, NOP World Health [...]
By
For Art’s Sake
CREATIVE review The Procardia ad series of the early 80s [...]
By

http://www.pharmavoice.com/?p=241735

Pharma Outlet
The pharmaceutical industry is facing a crucial short age in [...]
By

Kathleen H. Drennan

What’s on your mind: Opinions
WHAT’S on your mind Beyond the Basics A friendly work [...]
By
Raise Your Voice: Letters
The Creative Challenge I read your roundtable on the challenges [...]
By
Letter from the Editor
3 PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah [...]
By

Taren Grom, Editor

On The Cover

CROs: Mission Possible
MISSION ANALYSTS … JOSEPH AVELLONE,M.D. President and CEO,Veritas Medicine Inc., Cambridge, Mass.;Veritas Medicine is a leading provider of Internet and patientdatabase services to identify and recruit patients into appropriate clinical trials ALFRED G.CHILDERS,PH.D. Principal and president of administration, Magellan Laboratories Inc. Research Triangle Park, N.C.; Magellan is a pharmaceutical development organization (PDO) providing a complete [...]
By

Taren Grom, Editor

Features

Debby Jo Blank — Point-Blank
“IT’S NOT AS HARD AS IT SOUNDS,” Dr. Blank responds when asked how she juggles the myriad tasks assigned to her as chief business officer of healthcare and agriculture at Genencor International Inc. “Genencor has an objectivesetting process every year and we run the company by organizing our activities around our objectives. My purpose is [...]
By

Kim Ribbink

Image is Everything
Research into the human genome and intricate studies of disease states are opening the door to personalized therapy. But for those therapies to reach the right target audience, accurate and early diagnosis of disease are essential. Amersham Health, which develops and markets diagnostic pharmaceuticals for diagnosis of heart disease, circulatory disor ders, lung disease, diseases [...]
By

Kim Ribbink

The End of the Paper Chase
Responses to an ongoing survey and face to face discussions with executives from pharmaceutical and biotech companies reveal their greatest concerns and hopes as they begin to streamline the clinicaltrials process. IN AN EXCLUSIVE WITH PHARMAVOICE, ELLEN SEMPLE,VP, MARKETING, CB TECHNOLOGIES INC.EXPLAINS WHY YESTERDAY’S ARGUMENTS FOR PAPER PROCESSES NO LONGER RING TRUE While the majority [...]
By
E-learning: A Virtual Classroom
Pharmaceutical companies are jumping on board the etrain as a way to better manage their internal learning initiatives The THE CLICK MAY NEVER REPLACE THE NO. 2 PENCIL, but elearning is becoming the teacher’s pet in terms of reach, content flexibility, access, and alleviating outofoffice downtime and cost. “Elearning is gaining momentum, but as with [...]
By

Taren Grom, Editor

Sales Reps — What’s Up Doc?
The relationship between the pharmaceutical sales representative and the physician has undergone a dramatic shift in recent years. In the past, the sales representative provided value to the physician, had an established and meaningful rela tionship, engaged in an interactive dialog, and acted as a company spokesperson. Today, according to industry executives, the role of [...]
By

Lynda Sears

Creating Opportunity From Diversity
bring messages about their products to diverse groups in a way that is culturally sensitive, that will garner longterm goodwill of the communities, and that address the most press ing health concerns facing various racial and ethnic groups. Developing diverse marketing promotions and programs where each group is recognized as an integral part of the [...]
By

Kim Ribbink

FEEDBACK